Philip H. Hamann

Bristol, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 11 publications

Five years of the Digital Rheumatology Network: insights and future directions.

Five years of the Digital Rheumatology Network: insights and future directions.

Journal: EULAR rheumatology open

Published: June 29, 2026

Rheumatic Manifestations of Sarcoidosis.

Rheumatic Manifestations of Sarcoidosis.

Journal: Diagnostics (Basel, Switzerland)

Published: November 18, 2024

How and Who? Examining Real-World Evidence of Engagement and Use of an Electronic Patient-Reported Outcome Smartphone Application in Routine Clinical Care for Patients With Inflammatory Arthritides.

How and Who? Examining Real-World Evidence of Engagement and Use of an Electronic Patient-Reported Outcome Smartphone Application in Routine Clinical Care for Patients With Inflammatory Arthritides.

Journal: ACR open rheumatology

Published: November 12, 2024

Recommendation to implementation of remote patient monitoring in rheumatology: lessons learned and barriers to take.

Recommendation to implementation of remote patient monitoring in rheumatology: lessons learned and barriers to take.

Journal: RMD open

Published: August 04, 2023

Capturing remote disease activity - results of a 12-month clinical pilot of a smartphone app in NHS rheumatology clinics in Bristol.

Capturing remote disease activity - results of a 12-month clinical pilot of a smartphone app in NHS rheumatology clinics in Bristol.

Journal: Rheumatology (Oxford, England)

Published: December 12, 2019

Early response to anti-TNF predicts long-term outcomes including sustained remission: an analysis of the BSRBR-RA.

Early response to anti-TNF predicts long-term outcomes including sustained remission: an analysis of the BSRBR-RA.

Journal: Rheumatology (Oxford, England)

Published: February 27, 2019

Predictors, demographics and frequency of sustained remission and low disease activity in anti-tumour necrosis factor-treated rheumatoid arthritis patients.

Predictors, demographics and frequency of sustained remission and low disease activity in anti-tumour necrosis factor-treated rheumatoid arthritis patients.

Journal: Rheumatology (Oxford, England)

Published: September 26, 2018

Gender stratified adjustment of the DAS28-CRP improves inter-score agreement with the DAS28-ESR in rheumatoid arthritis.

Gender stratified adjustment of the DAS28-CRP improves inter-score agreement with the DAS28-ESR in rheumatoid arthritis.

Journal: Rheumatology (Oxford, England)

Published: May 30, 2018

Factors Associated With Sustained Remission in Rheumatoid Arthritis in Patients Treated With Anti-Tumor Necrosis Factor.

Factors Associated With Sustained Remission in Rheumatoid Arthritis in Patients Treated With Anti-Tumor Necrosis Factor.

Journal: Arthritis care & research

Published: April 13, 2016

Reactivity in ELISA with DNA-loaded nucleosomes in patients with proliferative lupus nephritis.

Reactivity in ELISA with DNA-loaded nucleosomes in patients with proliferative lupus nephritis.

Journal: Molecular immunology

Published: April 09, 2015

Statin-induced necrotizing myositis - a discrete autoimmune entity within the "statin-induced myopathy spectrum".

Statin-induced necrotizing myositis - a discrete autoimmune entity within the "statin-induced myopathy spectrum".

Journal: Autoimmunity reviews

Published: July 01, 2013

Showing 1-11 of 11

Last Updated: 09/26/2026